Erschienen in:
21.03.2021 | Images that Teach
Potential utility of 18F-NaF PET/CT in cardiac amyloidosis
verfasst von:
Yuki Tani, MD, Takashi Norikane, MD, PhD, Yasukage Takami, MD, PhD, Katsuya Mitamura, MD, PhD, Yuka Yamamoto, MD, PhD, Masatoshi Morimoto, RT, Takahisa Noma, MD, PhD, Yoshihiro Nishiyama, MD, PhD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 6/2022
Einloggen, um Zugang zu erhalten
Excerpt
Cardiac amyloidosis (CA) is characterized by the deposition of insoluble misfolded proteins in the myocardium. CA is classified based on the type of protein accumulating in the myocardium with two main recognized subtypes: transthyretin (ATTR) CA and light-chain (AL) CA. Recently, there has been emerging interest in using
18F-sodium fluoride (
18F-NaF) positron emission tomography (PET) to evaluate ATTR CA.
1,
2 …